Caregiver Action Network Announces New Resource for Families of Loved Ones with Heart Failure
08 juin 2021 13h46 HE
|
Caregiver Action Network
Washington, DC, June 08, 2021 (GLOBE NEWSWIRE) -- Hearing that a loved one has been diagnosed with heart failure brings fear, stress, and a whole lot of questions. Caregiver Action Network has...
Clinical Highlights: 2021 CMHC Spring Cardiometabolic Health Congress
22 avr. 2021 16h32 HE
|
Cardiometabolic Health Congress
Boca Raton, FL, April 22, 2021 (GLOBE NEWSWIRE) -- Clinical Highlights: 2021 CMHC Spring Cardiometabolic Health Congress Top Experts Convene to Discuss the Syndemic of COVID-19 &...
Fierce Medtech Names CVRx as One of its “Fierce 15” Companies
15 mars 2021 10h00 HE
|
CVRx, Inc.
MINNEAPOLIS, March 15, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announces it has been selected...
BERLIN HEALS Announces results of first-in-human study for its Implantable C-MIC device for the Treatment of Heart Failure with Electrical Microcurrent and the Launch of a pivotal CE Mark Study
04 mars 2021 11h00 HE
|
Berlin Heals Holding AG
BERLIN and ZUG, Switzerland, March 04, 2021 (GLOBE NEWSWIRE) -- BERLIN HEALS, a company dedicated to developing and offering novel and life-saving treatments for patients suffering from heart...
CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients
28 janv. 2021 08h00 HE
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Jan. 28, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CHF Solutions Offers Educational Event on Effective Fluid Management Strategies in Heart Failure Patients
21 janv. 2021 08h00 HE
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Jan. 21, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
CVRx® Appoints New Chief Marketing Officer and Vice President of European Sales and Marketing
05 janv. 2021 10h55 HE
|
CVRx, Inc.
MINNEAPOLIS, Jan. 05, 2021 (GLOBE NEWSWIRE) -- CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced that it is expanding...
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Heart Failure Study as Designed
17 déc. 2020 08h30 HE
|
BioCardia, Inc.
SAN CARLOS, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) -- BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that...
CHF Solutions Announces Meta-Analysis Demonstrates Ultrafiltration is Better than Diuretic Therapy for the Management of Volume Overload in ADHF
15 déc. 2020 08h00 HE
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today...
Global Atrial Fibrillation Treatment Market (2020 to 2025) - Industry Trends, Share, Size, Growth, Opportunity and Forecast
10 déc. 2020 04h13 HE
|
Research and Markets
Dublin, Dec. 10, 2020 (GLOBE NEWSWIRE) -- The "Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...